Esophagogastric Junction/Gastric Adenocarcinoma

1

Review clinical trials related to Esophagogastric Junction/Gastric Adenocarcinoma. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

A Study on Immunotherapy Combined With Radiotherapy for Esophagogastric Junction/Gastric Adenocarcinoma

A single-arm, prospective phase II clinical study of neoadjuvant PD-1/CTLA-4 combination antibody with low-dose radiotherapy in resectable dMMR/MSI-H esophagogastric junction/gastric adenocarcinoma.

Participants needed: 20
Trial details
Phase: Phase 2Age: 18-80Biological sex: AllType: InterventionalSponsor: Jiangsu Cancer Institute & HospitalUpdated: Jul 8, 2025
Eligibility criteria

Patients voluntarily participate in this study, sign the informed consent form,... [+13]

History of surgery for gastric or gastroesophageal junction tumor; [+22]